Anita Hill

4.4k total citations
62 papers, 2.7k citations indexed

About

Anita Hill is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Anita Hill has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 27 papers in Hematology and 19 papers in Genetics. Recurrent topics in Anita Hill's work include Complement system in diseases (42 papers), Blood groups and transfusion (21 papers) and Renal Diseases and Glomerulopathies (14 papers). Anita Hill is often cited by papers focused on Complement system in diseases (42 papers), Blood groups and transfusion (21 papers) and Renal Diseases and Glomerulopathies (14 papers). Anita Hill collaborates with scholars based in United Kingdom, United States and Germany. Anita Hill's co-authors include Beverley M. Shields, Andrew T. Hattersley, Timothy J. McDonald, Stephen J. Richards, Angus G. Jones, Bridget Knight, Peter Hillmen, Richard Kelly, Michael N. Weedon and Richard A. Oram and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anita Hill

61 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anita Hill United Kingdom 27 1.4k 847 702 648 518 62 2.7k
Frank Bienaimé France 18 801 0.6× 952 1.1× 51 0.1× 347 0.5× 197 0.4× 38 1.8k
Emese Kiss Hungary 34 1.2k 0.9× 154 0.2× 275 0.4× 365 0.6× 265 0.5× 130 3.2k
Andrew W. Minto United States 23 591 0.4× 775 0.9× 111 0.2× 109 0.2× 112 0.2× 36 2.0k
B. Mougenot France 29 307 0.2× 1.2k 1.4× 39 0.1× 522 0.8× 242 0.5× 67 3.0k
Marina Charbit France 22 299 0.2× 571 0.7× 45 0.1× 131 0.2× 182 0.4× 62 1.6k
Ladan Zand United States 25 641 0.5× 1.6k 1.8× 23 0.0× 331 0.5× 91 0.2× 90 2.2k
Edward L. Amorosi United States 15 765 0.5× 385 0.5× 50 0.1× 664 1.0× 56 0.1× 27 1.6k
Yoshiyuki Ohtomo Japan 21 144 0.1× 761 0.9× 117 0.2× 184 0.3× 175 0.3× 91 1.5k
Michael Venning United Kingdom 17 538 0.4× 970 1.1× 29 0.0× 250 0.4× 66 0.1× 44 1.9k
Gary Ferrell United States 15 529 0.4× 249 0.3× 18 0.0× 1.3k 1.9× 108 0.2× 16 1.9k

Countries citing papers authored by Anita Hill

Since Specialization
Citations

This map shows the geographic impact of Anita Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Hill more than expected).

Fields of papers citing papers by Anita Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Hill. The network helps show where Anita Hill may publish in the future.

Co-authorship network of co-authors of Anita Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Hill. A scholar is included among the top collaborators of Anita Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Hill. Anita Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kibirige, Davis, Jean-Claude Katte, Anita Hill, et al.. (2024). Ethnic differences in the manifestation of early-onset type 2 diabetes. BMJ Open Diabetes Research & Care. 12(4). e004174–e004174. 4 indexed citations
2.
Rodgers, Lauren R., Anita Hill, John Dennis, et al.. (2021). Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study. BMC Medicine. 19(1). 184–184. 9 indexed citations
3.
Hammersley, S., Timothy J. McDonald, Beverley M. Shields, et al.. (2019). Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?. Diabetic Medicine. 36(9). 1092–1099. 27 indexed citations
4.
Lynam, Anita L., Timothy J. McDonald, Anita Hill, et al.. (2019). Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years. BMJ Open. 9(9). e031586–e031586. 44 indexed citations
5.
Kulasekararaj, Austin, Anita Hill, Saskia Langemeijer, et al.. (2019). One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment. Blood. 134(Supplement_1). 2231–2231. 5 indexed citations
6.
Dennis, John, Beverley M. Shields, Anita Hill, et al.. (2018). Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy. Diabetes Care. 41(4). 705–712. 59 indexed citations
7.
Shields, Beverley M., Timothy J. McDonald, Richard A. Oram, et al.. (2018). C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase. Diabetes Care. 41(7). 1486–1492. 75 indexed citations
8.
Hill, Anita, Miles A. Nunn, Tadeusz Robak, et al.. (2017). Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial. Blood. 130. 4747–4747. 4 indexed citations
9.
10.
Hope, S, Bridget Knight, Beverley M. Shields, et al.. (2017). Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia. Diabetologia. 61(1). 66–74. 31 indexed citations
11.
Jones, Angus G., Timothy J. McDonald, Beverley M. Shields, et al.. (2015). Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes. Diabetes Care. 39(2). 250–257. 125 indexed citations
12.
Kelly, Richard J., Britta Höchsmann, Austin Kulasekararaj, et al.. (2014). Eculizumab Treatment Improves Outcomes of Pregnancy in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 124(21). 4393–4393. 1 indexed citations
13.
Kelly, Richard, Anita Hill, Louise Arnold, et al.. (2011). Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 117(25). 6786–6792. 347 indexed citations
14.
Gulbis, Béatrice, Androulla Eleftheriou, Michael Angastiniotis, et al.. (2010). Epidemiology of Rare Anaemias in Europe. Advances in experimental medicine and biology. 686. 375–396. 60 indexed citations
15.
Shields, Beverley M., Rachel M. Freathy, Bridget Knight, et al.. (2009). Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 94(11). 4608–4612. 23 indexed citations
16.
Young, Neal S., Gabrielle Meyers, Hubert Schrezenmeier, Peter Hillmen, & Anita Hill. (2009). The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for Patients. Seminars in Hematology. 46(1 Suppl 1). S1–S16. 27 indexed citations
17.
Hill, Anita, Eric Van Den Neste, Petra Muus, et al.. (2008). Improvement in Fatigue With Eculizumab Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (pnh) Occurs Independent of Changes in Anemia. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 93. 359–359. 3 indexed citations
18.
Kelly, Richard, Louise Arnold, Stephen J. Richards, et al.. (2008). Successful Pregnancy Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Long-Term Eculizumab Treatment. Blood. 112(11). 4576–4576. 4 indexed citations
19.
Knight, Bridget, Beverley M. Shields, Anita Hill, et al.. (2007). The Impact of Maternal Glycemia and Obesity on Early Postnatal Growth in a Nondiabetic Caucasian Population. Diabetes Care. 30(4). 777–783. 51 indexed citations
20.
Knight, Bridget, Beverley M. Shields, Anita Hill, et al.. (2006). Offspring birthweight is not associated with paternal insulin resistance. Diabetologia. 49(11). 2675–2678. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Bienaimé Breakdown of academic impact, for papers by Emese Kiss Breakdown of academic impact, for papers by Andrew W. Minto Breakdown of academic impact, for papers by B. Mougenot Breakdown of academic impact, for papers by Marina Charbit Breakdown of academic impact, for papers by Ladan Zand Breakdown of academic impact, for papers by Edward L. Amorosi Breakdown of academic impact, for papers by Yoshiyuki Ohtomo Breakdown of academic impact, for papers by Michael Venning Breakdown of academic impact, for papers by Gary Ferrell
Rankless by CCL
2026